biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > so is that the end of JD? Prophet?

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 19, 2023 9:13pm

61 Views

Post# 35596669

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:so is that the end of JD? Prophet?

You're wrong, TT. Prophylaxis was discussed by Mark Day, DrDR and RH. The idea was that xB3-001 could kill diffuse tumours before they were detectable.

As a standard of care, xB3-001 was also discussed in the corporate presentation.

But you never bothered to read anything, TT, you and beenthere.

Maybe you should stick with attacking me. Repetition better suits your natural strengths.

jd

<< Previous

Bullboard Posts

Next >>

Cannabix advances marijuana breathalyzer tech